Skip to content
Companies

AgelessRx

Longevity telehealth and prescriptions by subscription

Raised to date

$5.5M

across 1 Form D filing

Investors
32
Last filed
Mar 17, 2026

About

AgelessRx is a direct-to-consumer telehealth company founded in 2020 that provides science-backed longevity treatments aimed at enhancing healthspan. The platform offers personalized protocols, prescription therapies, diagnostics, and supplements to address the root causes of aging. It operates on a subscription-based membership model, connecting users with licensed clinicians to facilitate preventive care.

The company positions itself as a pioneering, data-driven longevity platform that offers clinician-guided protocols that are continuously updated with patient data. A key differentiator is its operation of large, decentralized clinical trials, such as the PEARL trial for Rapamycin, which allows for real-world evidence gathering on a large scale.

Funding

  • EquityFiled Mar 17, 2026Form D
    $5.5M/ no target

Product

Personalized Longevity Telehealth Platform

Telehealth Platform

The core offering is a telehealth platform providing access to U.S.-licensed providers who guide patients through personalized longevity treatments. The service focuses on preventive care through science-backed protocols, prescription therapies like Metformin and NAD+, advanced diagnostics, and supplements addressing key areas such as metabolic health, sleep, and cognitive function.

  • Access to over 30 diagnostics and therapeutics
  • Protocols vetted by a Stanford PhD-led science team
  • Personalized treatment plans with ongoing updates based on patient data

Built for

The primary customers are individuals seeking proactive health management and scientifically-grounded anti-aging therapies to extend their healthspan.

People on file